#1 Clinical Trials Search in Europe

Dinoprostone

This article examines the use of dinoprostone, a prostaglandin E2 medication, in clinical trials for labor induction and cervical ripening. Dinoprostone is commonly used in various formulations, including vaginal inserts and gels, to prepare the cervix for labor and stimulate contractions in pregnant women at or near term. The trials discussed here compare dinoprostone to other methods and evaluate its efficacy and safety for both inpatient and outpatient use in different clinical scenarios.

Table of Contents

What is Dinoprostone?

Dinoprostone is a medication that belongs to a group of drugs called prostaglandins. Specifically, it is a prostaglandin E2 (PGE2) analog[1]. This means it mimics the action of naturally occurring prostaglandins in the body. Dinoprostone is known by several brand names, including Propess, Cervidil, and Prostin E2[2][3].

Uses of Dinoprostone

Dinoprostone is primarily used in obstetrics for the following purposes:

  • Cervical ripening: This is the process of softening and preparing the cervix for labor. Dinoprostone helps to make the cervix more favorable for induction of labor[4].
  • Induction of labor: Dinoprostone is used to start or continue the process of labor in pregnant women who are at or near the time of delivery[3].
  • Management of postterm pregnancies: It’s used in pregnancies that have gone beyond the expected due date[5].
  • Prelabor rupture of membranes (PROM): Dinoprostone can be used when the water breaks before labor starts[2].

In addition to its obstetric uses, recent research has explored the use of dinoprostone in gynecological procedures. For example, it has been studied for its potential to reduce bleeding during abdominal myomectomy (a surgery to remove uterine fibroids)[1].

How Dinoprostone Works

Dinoprostone works by mimicking the action of naturally occurring prostaglandins in the body. In the context of labor and delivery, it has several effects:

  • Cervical softening: It causes the cervix to become softer and more pliable[6].
  • Cervical dilation: It helps the cervix to open or dilate[6].
  • Uterine contractions: It can stimulate the uterus to contract, which is necessary for labor to progress[6].

Forms and Administration

Dinoprostone is available in several forms for vaginal administration:

  • Vaginal insert: This is a controlled-release form that slowly releases dinoprostone over time. It’s often referred to by brand names like Propess or Cervidil. The insert typically contains 10 mg of dinoprostone and releases it at a rate of about 0.3 mg per hour[6][3].
  • Vaginal gel: This form is applied directly to the cervix or vaginal fornix (the space around the cervix)[7].
  • Vaginal tablets: These are placed in the posterior vaginal fornix. They typically contain 3 mg of dinoprostone[6].

The specific form and dosage used can vary depending on the individual situation and the healthcare provider’s preference.

Effectiveness

Dinoprostone has been shown to be effective for cervical ripening and labor induction in many studies. Its effectiveness is often measured by factors such as:

  • Time from induction to delivery: This measures how quickly labor progresses after dinoprostone is administered[2].
  • Rate of successful vaginal delivery: This looks at how many women are able to deliver vaginally after receiving dinoprostone[5].
  • Changes in Bishop score: The Bishop score is a measure of how favorable the cervix is for labor. An increase in Bishop score indicates that the cervix is becoming more favorable[4].

However, it’s important to note that the effectiveness can vary from person to person, and other factors can influence the outcome of labor induction.

Side Effects and Safety

Like all medications, dinoprostone can have side effects. Some potential side effects include:

  • Uterine hyperstimulation: This is when the uterus contracts too frequently or too strongly. It can potentially cause distress to the baby[2].
  • Nausea and vomiting
  • Fever
  • Diarrhea

Healthcare providers carefully monitor patients receiving dinoprostone to watch for these side effects. The medication can be removed quickly if necessary (in the case of the vaginal insert), which is one of its safety features[4].

Comparison with Other Medications

Dinoprostone is often compared to other medications used for cervical ripening and labor induction, particularly misoprostol (a prostaglandin E1 analog). Some studies have directly compared these medications:

  • A study compared vaginal dinoprostone to vaginal misoprostol for induction of labor in post-date pregnancies. Both were found to be effective, but there may be differences in how quickly they work and their side effect profiles[5].
  • Another study looked at using these medications to reduce bleeding during abdominal myomectomy (fibroid removal surgery)[1].

The choice between dinoprostone and other medications often depends on factors specific to each patient and the preferences of the healthcare provider.

Research and Clinical Trials

Ongoing research continues to explore the uses and effectiveness of dinoprostone. Some areas of current research include:

  • Outpatient use: Some studies are looking at whether dinoprostone can be safely used for cervical ripening in an outpatient setting, allowing women to spend more time at home before coming to the hospital for delivery[3].
  • Use in specific populations: Research is examining how dinoprostone performs in different groups of women, such as those with premature rupture of membranes (when the water breaks before labor starts)[8].
  • Comparison with other methods: Studies continue to compare dinoprostone with other methods of cervical ripening and labor induction[5].
  • Non-obstetric uses: Some research is exploring the use of dinoprostone in other areas of gynecology, such as reducing bleeding during certain surgeries[1].

These ongoing studies help to refine our understanding of how best to use dinoprostone and may lead to new applications in the future.

Aspect Details
Main Uses Cervical ripening, labor induction
Administration Methods Vaginal inserts, gels, tablets
Common Formulations Propess, Prostin, Cervidil
Typical Dosages 3-10 mg, depending on formulation
Duration of Action Up to 24 hours for controlled-release inserts
Primary Outcomes Measured Time to delivery, successful vaginal delivery rate
Secondary Outcomes Cesarean section rate, patient satisfaction, neonatal outcomes
Safety Considerations Monitoring for uterine hyperstimulation, fetal heart rate changes
Emerging Research Areas Outpatient use, comparison with other induction methods

FAQ

  • What is dinoprostone used for in obstetrics? Dinoprostone is used for cervical ripening and labor induction in pregnant women at or near term. It helps soften and dilate the cervix and can stimulate uterine contractions to begin labor.
  • How is dinoprostone administered? Dinoprostone is typically administered vaginally, either as a gel, tablet, or controlled-release insert placed in the posterior vaginal fornix. The specific formulation and dosing can vary between products like Propess, Prostin, and Cervidil.
  • How long does dinoprostone take to work? The time for dinoprostone to take effect can vary. Some trials measure outcomes within 12-24 hours of administration. Controlled-release inserts like Propess are often left in place for up to 24 hours unless labor begins earlier.
  • What are the potential side effects of dinoprostone? Potential side effects can include uterine hyperstimulation (too frequent contractions), changes in fetal heart rate, and in rare cases, uterine rupture. Patients are typically monitored for these effects, especially in the first few hours after administration.
  • Can dinoprostone be used for outpatient cervical ripening? Some trials are investigating the use of dinoprostone for outpatient cervical ripening. This involves administering the medication and sending the patient home to return later for induction, potentially offering more comfort and reduced hospital costs. However, this approach is still being studied for safety and efficacy.

Ongoing Clinical Trials on Dinoprostone

  • Study of oxytocin, dinoprostone, and misoprostol combination for active management in pregnant women with premature rupture of membranes

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Comparison of Oxytocin versus Prostaglandins (Dinoprostone and Misoprostol) for Labor Induction in Women with Unfavorable Cervix After Initial Cervical Ripening

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study Comparing Cook’s Balloon and Dinoprostone for Inducing Labor in Pregnant Women with Fetal Growth Restriction at Term

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Cervical ripening: The process of softening, thinning, and sometimes beginning to open the cervix in preparation for labor and delivery.
  • Bishop score: A scoring system used to assess the readiness of the cervix for labor, taking into account factors like dilation, effacement, consistency, position, and fetal station.
  • Prostaglandin E2 (PGE2): A naturally occurring hormone-like substance that can be used medically to ripen the cervix and induce labor. Dinoprostone is a synthetic form of PGE2.
  • Vaginal insert: A medication delivery system placed in the vagina, such as the Propess or Cervidil inserts, which release dinoprostone over time.
  • Tachysystole: A condition where uterine contractions occur too frequently, typically defined as more than 5 contractions in 10 minutes, averaged over 30 minutes.
  • Prelabor rupture of membranes (PROM): The breaking of the amniotic sac before labor begins, also known as 'water breaking'.
  • Oxytocin: A hormone that can be given synthetically to induce or augment labor contractions.
  • Apgar score: A quick assessment of a newborn's condition shortly after birth, scored on a scale of 0-10 based on appearance, pulse, grimace, activity, and respiration.
  • Cesarean section: A surgical procedure to deliver a baby through incisions in the mother's abdomen and uterus.
  • Chorioamnionitis: An inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection.

References

  1. https://clinicaltrials.gov/study/NCT05761418
  2. https://clinicaltrials.gov/study/NCT05430711
  3. https://clinicaltrials.gov/study/NCT03806231
  4. https://clinicaltrials.gov/study/NCT03067597
  5. https://clinicaltrials.gov/study/NCT06560515
  6. https://clinicaltrials.gov/study/NCT01635439
  7. https://clinicaltrials.gov/study/NCT01390233
  8. https://clinicaltrials.gov/study/NCT04743297